menu
    • menu

    Company profile for Cellectis

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. Cellectis is focused on addressing the medical and food needs of an ever-growing global population through the use of proprietary gene-editing technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellectisFrance Flag
    Country
    Country
    France
    Address
    Address
    8 rue de la Croix Jarry 75013 Paris
    Telephone
    Telephone
    +33 (0)1 81 69 16 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellectis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cellectis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cellectis?lang=fr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Monthly Update: Share Capital & Voting Rights
    Monthly Update: Share Capital & Voting Rights

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3199378/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Moligo & Cellectis Show Enzymatic Dna's Gene Editing Potential
    Moligo & Cellectis Show Enzymatic Dna's Gene Editing Potential

    21 Nov 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/moligo-technologies-and-cellectis-demonstrate-potential-of-enzymatic-single-stranded-dna-for-non-viral-gene-editing-in-nature-communications-302622945.html

    PR NEWSWIRE BIO
    21 Nov 2025
    Share Share
    Cellectis Publish Breakthrough on Non-Viral Gene Editing Process
    Cellectis Publish Breakthrough on Non-Viral Gene Editing Process

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190757/0/en/Cellectis-Publishes-Nature-Communications-Article-on-a-Non-Viral-Gene-Editing-Process-Enabling-Efficient-Gene-Insertion-in-Hematopoietic-Stem-Cells.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Monthly Information On Share Capital & Company Voting Rights
    Monthly Information On Share Capital & Company Voting Rights

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183826/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Cellectis Reveals Q3 2025 Financials and Business Update
    Cellectis Reveals Q3 2025 Financials and Business Update

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183985/0/en/Cellectis-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Cellectis To Present Development Update For Eti-Cel at ASH 2025
    Cellectis To Present Development Update For Eti-Cel at ASH 2025

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179424/0/en/Cellectis-to-Present-a-Development-Update-for-eti-cel-at-ASH-2025.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search